1.Gallbladder Paraganglioma Associated with SDHD Mutation: a Potential Pitfall on ¹⁸F-FDOPA PET Imaging
Zahraa Abdul SATER ; Abhishek JHA ; Adel MANDL ; Sheila K MANGELEN ; Jorge A CARRASQUILLO ; Alexander LING ; Melissa K GONZALES ; Osorio LOPES ABATH NETO ; Markku MIETTINEN ; Karen T ADAMS ; Pavel NOCKEL ; Mustapha EL LAKIS ; Karel PACAK
Nuclear Medicine and Molecular Imaging 2019;53(2):144-147
A 36-year-old male patient initially presented with hypertension, tinnitus, bilateral carotid masses, a right jugular foramen, and a periaortic arch mass with an elevated plasma dopamine level but an otherwise normal biochemical profile. On surveillance MRI 4 years after initial presentation, he was found to have a 2.2-cm T2 hyperintense lesion with arterial enhancement adjacent to the gallbladder, which demonstrated avidity on ⁶⁸Ga-DOTATATE PET/CTand retrospectively on ¹⁸F-FDOPA PET/CT but was nonavid on ¹⁸F-FDG PET/CT. Biochemical work-up including plasma catecholamines, metanephrines, and chromogranin A levels were found to be within normal limits. This lesion was surgically resected and was confirmed to be a paraganglioma (PGL) originating from the gallbladder wall on histopathology. Pheochromocytoma (PHEO) and PGL are rare tumors of the autonomic nervous system. Succinate dehydrogenase subunit D (SDHD) pathogenic variants of the succinate dehydrogenase complex are usually involved in parasympathetic, extra-adrenal, multifocal head, and neck PGLs. We report an unusual location of PGL in the gallbladder associated with SDHD mutation which could present as a potential pitfall on ¹⁸F-FDOPA PET/CT as its normal excretion occurs through biliary system and gallbladder. This case highlights the superiority of ⁶⁸Ga-DOTATATE in comparison to ¹⁸F-FDOPA and ¹⁸F-FDG in the detection of SDHD-related parasympathetic PGL.ClinicalTrials.gov Identifier: NCT00004847.
Adult
;
Autonomic Nervous System
;
Biliary Tract
;
Catecholamines
;
Chromogranin A
;
Dopamine
;
Gallbladder
;
Head
;
Humans
;
Hypertension
;
Magnetic Resonance Imaging
;
Male
;
Neck
;
Paraganglioma
;
Pheochromocytoma
;
Plasma
;
Positron-Emission Tomography and Computed Tomography
;
Retrospective Studies
;
Succinate Dehydrogenase
;
Tinnitus
2.Gallbladder Paraganglioma Associated with SDHD Mutation: a Potential Pitfall on ¹â¸F-FDOPA PET Imaging
Zahraa Abdul SATER ; Abhishek JHA ; Adel MANDL ; Sheila K MANGELEN ; Jorge A CARRASQUILLO ; Alexander LING ; Melissa K GONZALES ; Osorio LOPES ABATH NETO ; Markku MIETTINEN ; Karen T ADAMS ; Pavel NOCKEL ; Mustapha EL LAKIS ; Karel PACAK
Nuclear Medicine and Molecular Imaging 2019;53(2):144-147
A 36-year-old male patient initially presented with hypertension, tinnitus, bilateral carotid masses, a right jugular foramen, and a periaortic arch mass with an elevated plasma dopamine level but an otherwise normal biochemical profile. On surveillance MRI 4 years after initial presentation, he was found to have a 2.2-cm T2 hyperintense lesion with arterial enhancement adjacent to the gallbladder, which demonstrated avidity on â¶â¸Ga-DOTATATE PET/CTand retrospectively on ¹â¸F-FDOPA PET/CT but was nonavid on ¹â¸F-FDG PET/CT. Biochemical work-up including plasma catecholamines, metanephrines, and chromogranin A levels were found to be within normal limits. This lesion was surgically resected and was confirmed to be a paraganglioma (PGL) originating from the gallbladder wall on histopathology. Pheochromocytoma (PHEO) and PGL are rare tumors of the autonomic nervous system. Succinate dehydrogenase subunit D (SDHD) pathogenic variants of the succinate dehydrogenase complex are usually involved in parasympathetic, extra-adrenal, multifocal head, and neck PGLs. We report an unusual location of PGL in the gallbladder associated with SDHD mutation which could present as a potential pitfall on ¹â¸F-FDOPA PET/CT as its normal excretion occurs through biliary system and gallbladder. This case highlights the superiority of â¶â¸Ga-DOTATATE in comparison to ¹â¸F-FDOPA and ¹â¸F-FDG in the detection of SDHD-related parasympathetic PGL.ClinicalTrials.gov Identifier: NCT00004847.